Explore a diverse range of topics and expertise through our seminar series at the Blumberg Institute. Our Industry Speakers series offers valuable industry insights, while the Young Investigator Seminars showcase cutting-edge research. Our Invited Seminars feature esteemed guests. Join us in cultivating collaboration, fostering innovation, and promoting academic excellence.
All seminars, unless noted, take place at our headquarters at the Pennsylvania Biotechnology Center at 3805 Old Easton Road, Doylestown, PA 18902, in Room 3100.
No registration required.
Oct. 7, 2026
Norbert Pardi, PhD, Associate Professor, Department of Microbiology, Perelman School of Medicine, UPenn
“Lipid Nanoparticles for mRNA Vaccine Delivery”
Oct. 20, 2026
Simon Fletcher, PhD, Vice President, Virology, Gilead Sciences
“Long-Acting HSV Inhibitors for the Treatment of Recurrent Genital Herpes”
(If Available)
Oct. 1 2026
Georg Lauer, MD, PhD, Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School
“The Long and Winding Road from Chronic Hepatitis B to Functional Care”
July 30, 2026
Chris Moore, PhD, Chief Scientific Officer, XenImmune Therapeutics
Painting Tumors: Redirecting Natural Immunity with Antibody Glycozyme Fusions
July 23, 2026
Michaela Gack, PhD, Scientific Director, Cleveland Clinic Florida Research & Innovation Center
Innate and intrinsic host enzymes shaping RNA virus infection
June 4, 2026
Sumita Bhaduri-McIntosh, PhD, Professor, Pediatrics and Molecular Genetics & Microbiology; Member, UF Health Cancer Institute, University of Florida
& Michael McIntosh, PhD, Professor of Pediatrics, Child Health Research Institute, University of Florida
Harnessing the Ubiquitin-Proteasome System to Kill EBV-Positive Cancers
March 5, 2026
Nicholas Dopkins, PhD, Instructor of Immunovirology
Endogenous Retrovirus Activity in Health and Disease
Feb. 26, 2026
Xuping Xie, PhD, Associate Professor, Department of Microbiology & Immunology, utmb Health
NS4B-Targeted Dengue Antivirals: More Work Ahead
Jan. 22, 2026
Maurie Smith, Managing Director, Keystone LifeSci Collaborative
Beyond the Bench: Building a Connected Talent Ecosystem for SEPA Life Sciences
Joseph Salvino, PhD, Professor, Molecular and Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center
Developing Wild-Type IDH1 Inhibitors to Treat Pancreatic Cancer
Nov. 21, 2025
Frances Platt, FMedSci FRS, Head of Department, University of Oxford
Converging Pathways in Neurodegeneration: From Bench to Bedside
Nov. 6, 2025
Robert Edward Schwartz, MD, PhD, Associate Professor of Medicine at the Sanford
A Nucleosome Switch Primes Hepatitis B Virus Infection
Aug. 26, 2025
Dongmei Wang, PhD, Executive Vice President, Frontage Lab
From Lead Compound to IND
Aug. 18, 2025
Xiangbing Qi, PhD, Principal Investigator National Institute of Biological Sciences, Beijing, China
Small-Molecule Drug Discovery and Development Targeting NTCP as a Therapeutic Inhibitor
July 24, 2025
Karim Mouzannar, PhD, Postdoctoral Fellow at Liver Diseases Branch, NIDDK, NIH
A Proteomic Approach Identifies the COP9 Signalosome as a Key Host Factor in an Early Step of Hepatitis B Virus Life Cycle
July 3, 2025
Alison Axtman, PhD, Assistant Professor, Division of Chemical Biology and Medicinal Chemistry, Principal Investigator of Medicinal Chemistry in SGC-UNCD
Tuning a Privileged Chemical Scaffold to Target Poorly Characterized Kinases
June 19, 2025
Ju-Tao Guo, MD, Acting President & CSO, Baruch S. Blumberg Institute
Molecular Biology of Hepatitis B Virus cccDNA and Implications in the Cure of Chronic Hepatitis B
June 10, 2025
Shun-Hua Chen, PhD, Professor Shun-Hua Chen, Department Microbiology & Immunology, College of Medicine, National Cheng Kung University, Taiwan
Searching Antivirals and mRNA Vaccines Against Coxsackievirus B3 Using a Murine Infection Model
June 6, 2025
Qinglin Tang, PhD, CEO Convalife, Shanghai
Phase Appropriate CMC Development of an NCE for IND
May 15, 2025
Eda Canales, PhD, Director, Medicinal Chemistry, Gilead Sciences
Lenacapavir, a First-in-class Long-Acting HIV Capsid Inhibitor
May 6, 2025
Susan R. Weiss, PhD, Professor and Vice Chair Department of Microbiology, Perleman School of Medicine, University of Pennsylvania
Coronavirus activation and antagonism of interferon signaling pathways